Our B2B Services
Precision Against MDR
Phages, due to their remarkable specificity, are ideally suited as precision therapeutics. However, this same specificity can also pose a challenge: each bacterial strain requires a uniquely matched phage to ensure effective targeting.
With hundreds of bacterial strains often circulating in hospital environments—and their distributions frequently unknown—selecting the right phages becomes complex.
Genomic Surveillance
To overcome this, we have developed a cutting-edge genomic surveillance pipeline. This process provides critical insights into the diversity and prevalence of targeted bacterial pathogens and identifies the phages that work best against them. Our approach produces detailed, region-specific maps that reveal the distribution and spread of key bacterial types, allowing us to pinpoint exactly where matching strains exist.
What We Offer
We localize pathogens and monitor the global geographic distribution of bacterial strains, supporting patient recruitment and clinical trial validation. These data-driven insights enable yous to prioritize your phage selections early in the development process, targeting the strains most prevalent in specific regions. This creates a scalable, cost-effective foundation for personalized phage therapy in real-world healthcare settings on a global scale.
​Contact us to learn how our surveillance services can support you in the fight against antimicrobial resistance.